| Product NDC: | 59115-096 |
| Proprietary Name: | Levofloxacin |
| Non Proprietary Name: | Levofloxacin |
| Active Ingredient(s): | 500 mg/1 & nbsp; Levofloxacin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 59115-096 |
| Labeler Name: | Hikma Pharmaceutical |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078767 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110621 |
| Package NDC: | 59115-096-50 |
| Package Description: | 50 TABLET in 1 BOTTLE (59115-096-50) |
| NDC Code | 59115-096-50 |
| Proprietary Name | Levofloxacin |
| Package Description | 50 TABLET in 1 BOTTLE (59115-096-50) |
| Product NDC | 59115-096 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Levofloxacin |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110621 |
| Marketing Category Name | ANDA |
| Labeler Name | Hikma Pharmaceutical |
| Substance Name | LEVOFLOXACIN |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |